- Home
- FGEN vs MDAI Comparison
FGEN vs MDAI Comparison
Compare FGEN & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- MDAI
- Stock Information
- Founded
- FGEN 1993
- MDAI 2013
- Country
- FGEN United States
- MDAI United States
- Employees
- FGEN N/A
- MDAI N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- MDAI Medical/Dental Instruments
- Sector
- FGEN Health Care
- MDAI Health Care
- Exchange
- FGEN Nasdaq
- MDAI Nasdaq
- Market Cap
- FGEN 34.5M
- MDAI 28.3M
- IPO Year
- FGEN 2014
- MDAI N/A
- Fundamental
- Price
- FGEN $0.71
- MDAI $1.95
- Analyst Decision
- FGEN Strong Buy
- MDAI Strong Buy
- Analyst Count
- FGEN 1
- MDAI 2
- Target Price
- FGEN $10.00
- MDAI $4.75
- AVG Volume (30 Days)
- FGEN 7.2M
- MDAI 616.5K
- Earning Date
- FGEN 03-04-2025
- MDAI 03-26-2025
- Dividend Yield
- FGEN N/A
- MDAI N/A
- EPS Growth
- FGEN N/A
- MDAI N/A
- EPS
- FGEN N/A
- MDAI N/A
- Revenue
- FGEN $180,015,000.00
- MDAI $27,264,000.00
- Revenue This Year
- FGEN $21.91
- MDAI $61.78
- Revenue Next Year
- FGEN N/A
- MDAI N/A
- P/E Ratio
- FGEN N/A
- MDAI N/A
- Revenue Growth
- FGEN 16.15
- MDAI 44.52
- 52 Week Low
- FGEN $0.18
- MDAI $0.82
- 52 Week High
- FGEN $2.80
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- FGEN 65.95
- MDAI 45.75
- Support Level
- FGEN $0.54
- MDAI $1.86
- Resistance Level
- FGEN $0.88
- MDAI $2.25
- Average True Range (ATR)
- FGEN 0.07
- MDAI 0.15
- MACD
- FGEN 0.02
- MDAI -0.00
- Stochastic Oscillator
- FGEN 59.79
- MDAI 37.50
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.